Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||
Neoplasms
|
1644 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.100 | 0.900 | 10 | 2006 | 2017 | |||||
Liver carcinoma
|
942 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.050 | 0.800 | 5 | 2008 | 2017 | |||||
Malignant Neoplasms
|
1641 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2007 | 2019 | |||||
melanoma
|
515 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2009 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2007 | 2019 | |||||
Cutaneous Melanoma
|
248 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2008 | 2014 | |||||
Adenocarcinoma Of Esophagus
|
81 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2010 | 2013 | |||||
Colorectal Carcinoma
|
1962 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2011 | 2015 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||
Endometrial Carcinoma
|
326 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Li-Fraumeni Syndrome
|
206 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2011 | 2015 | |||||
Malignant neoplasm of endometrium
|
197 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Malignant neoplasm of soft tissue
|
32 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2012 | 2015 | |||||
Renal Cell Carcinoma
|
288 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||
Sarcoma
|
42 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Squamous cell carcinoma
|
257 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2009 | 2009 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Adult Myelodysplastic Syndrome
|
20 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Blast Phase
|
14 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Carcinoma of lung
|
1204 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 |